Onconova Therapeutics’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Ramesh Kumar Good afternoon and thank you for joining us. 2013 was an important year for Onconova and for our lead product candidate, rigosertib. In 2013, we completed patient enrollment in the Phase 3 … more

View todays social media effects on ONTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Onconova is hiring next, click here to view